Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TiGenix announces approval of trade name for lead development candidate Cx601 in Europe

$
0
0
PRESS RELEASE TiGenix announces approval of trade name for lead development candidate Cx601 in Europe International Nonproprietary Name INN darvadstrocel approved for Cx601 ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ Leuven BELGIUM November 16 2017 7h00 CET TiGenix NV Euro...

Viewing all articles
Browse latest Browse all 2985

Trending Articles